Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model
作者:Andrew J. Tague、Papanin Putsathit、Melanie L. Hutton、Katherine A. Hammer、Steven M. Wales、Daniel R. Knight、Thomas V. Riley、Dena Lyras、Paul A. Keller、Stephen G. Pyne
DOI:10.1016/j.ejmech.2019.02.068
日期:2019.5
treatments for C. difficile infection with improved efficacy are urgently needed. A streamlined synthetic pathway was developed to allow access to 38 novel mono- and di-cationic biaryl 1,2,3-triazolyl peptidomimetics with increased synthetic efficiency, aqueous solubility and enhanced antibacterial efficacy. The monocationic arginine derivative 28 was identified as a potent, Gram-positive selective antibacterial
Clostridioides(原梭菌)艰难是革兰氏阳性厌氧细菌病原体引起严重的胃肠道感染人类。当前的化学治疗方案非常不足,昂贵且有限。这导致了巨大的医疗和财务负担。迫切需要新的,廉价的,对艰难梭菌感染进行化学治疗的方法,以提高疗效。开发了一种简化的合成途径,以允许获得38种新颖的单和双阳离子联芳基1,2,3-三唑基肽模拟物,具有提高的合成效率,水溶性和增强的抗菌功效。单阳离子精氨酸衍生物28被鉴定为有效的革兰氏阳性选择性抗菌剂,对耐甲氧西林的金黄色葡萄球菌的MIC值为4μg/ mL,对艰难梭菌的MIC值为8μg/ mL 。此外,发现双效三唑类似物50具有广谱活性,并且对鲍曼不动杆菌(8μg/ mL),铜绿假单胞菌(8μg/ mL)和肺炎克雷伯菌(16μg/ mL)具有显着的革兰氏阴性功效。; 此外,化合物50在体外的溶血活性降低(<13%)溶血分析。在选定的衍生物上进行膜破坏试验,以确认合